Of note, apart from promoting an immune-suppressive tumor microenvironment, STAT3 signaling in breast cancer cells not only contributes to proliferation and metastatic behavior but also mediates immune evasion and resistance to cyclin-dependent kinase inhibitors (CDKi) [42,43]. The gene discussed is STAT3; the disease is breast cancer.